REGENXBIO Inc.
US ˙ NasdaqGS ˙ US75901B1070

Introduction

This page provides a comprehensive analysis of the known insider trading history of Luke M Beshar. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Luke M Beshar has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TARA / Protara Therapeutics, Inc. Director 198,000
US:TRIL / Trillium Therapeutics Inc Director 0
US:OMGA / Omega Therapeutics, Inc. Director 52,941
US:RGNX / REGENXBIO Inc. Director 10,000
US:NPSP / NPS Pharmaceuticals Inc EVP & CFO 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Luke M Beshar. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases RGNX / REGENXBIO Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in RGNX / REGENXBIO Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RGNX / REGENXBIO Inc. Insider Trades
Insider Sales RGNX / REGENXBIO Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in RGNX / REGENXBIO Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RGNX / REGENXBIO Inc. Insider Trades
Insider Purchases TARA / Protara Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in RGNX / REGENXBIO Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-06-30 TARA BESHAR LUKE M 10,000 3.1000 10,000 3.1000 31,000 75 4.2700 11,700 37.74
2022-03-14 TARA BESHAR LUKE M 10,000 4.2500 10,000 4.2500 42,500
2022-03-10 TARA BESHAR LUKE M 10,000 4.4555 10,000 4.4555 44,555

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARA / Protara Therapeutics, Inc. Insider Trades
Insider Sales TARA / Protara Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in RGNX / REGENXBIO Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARA / Protara Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Luke M Beshar as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-07-05 2022-06-30 4 TARA Protara Therapeutics, Inc.
Common Stock
P - Purchase 10,000 198,000 5.32 3.10 31,000 613,800
2022-03-16 2022-03-14 4 TARA Protara Therapeutics, Inc.
Common Stock
P - Purchase 10,000 188,000 5.62 4.25 42,500 799,000
2022-03-14 2022-03-10 4 TARA Protara Therapeutics, Inc.
Common Stock
P - Purchase 10,000 178,000 5.95 4.46 44,555 793,079
2021-11-19 2021-11-17 4 TRIL Trillium Therapeutics Inc.
Deferred Share Unit
D - Sale to Issuer -547,656 0 -100.00
2021-11-19 2021-11-17 4 TRIL Trillium Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -6,666 0 -100.00
2021-11-19 2021-11-17 4 TRIL Trillium Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -40,000 0 -100.00
2021-07-30 2021-07-29 4 OMGA Omega Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 52,941 52,941
2021-06-10 2021-06-09 4 TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-06-08 2021-06-04 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2020-06-11 2020-06-09 4 TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 9,000 9,000
2020-06-11 2020-01-09 4/A TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 6,676 6,676
2020-06-11 2020-01-09 4/A TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,399 12,399
2020-06-02 2020-05-29 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2020-01-13 2020-01-10 4 TARA ArTara Therapeutics, Inc.
Common Stock
A - Award 168,000 168,000
2020-01-13 2020-01-09 4 TARA ArTara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,491 10,491
2020-01-13 2020-01-09 4 TARA ArTara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 6,676 6,676
2020-01-13 2020-01-09 4 TARA ArTara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,399 12,399
2019-06-04 2019-05-31 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2018-12-03 2018-11-29 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -12,784 53,000 -19.43
2018-12-03 2018-11-29 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -12,784 0 -100.00 65.00 -830,960
2018-12-03 2018-11-29 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 12,784 12,784 3.76 48,068 48,068
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -716 65,784 -1.08
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 0 -100.00
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 0 -100.00
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -4,687 0 -100.00
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -883 7,292 -10.80
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -18,786 0 -100.00 65.03 -1,221,654
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 716 18,786 3.96 3.76 2,692 70,635
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 6,250 18,070 52.88 12.74 79,625 230,212
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 6,250 11,820 112.21 18.85 117,812 222,807
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 4,687 5,570 530.80 22.00 103,114 122,540
2018-11-28 2018-11-27 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 883 883 49.45 43,664 43,664
2018-11-28 2018-11-26 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -1,721 8,175 -17.39
2018-11-28 2018-11-26 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -1,721 0 -100.00 65.00 -111,865
2018-11-28 2018-11-26 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 1,721 1,721 49.45 85,103 85,103
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -13,500 66,500 -16.88
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -2,988 6,250 -32.34
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -4,688 4,687 -50.01
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -21,176 0 -100.00 60.38 -1,278,607
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 13,500 21,176 175.87 3.76 50,760 79,622
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 2,988 7,676 63.74 12.74 38,067 97,792
2018-11-21 2018-11-20 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 4,688 4,688 22.00 103,136 103,136
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -3,262 9,238 -26.10
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 6,250 -50.00
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
M - Exercise X -2,604 9,896 -20.83
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -600 0 -100.00 63.53 -38,118
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -600 600 -50.00 62.81 -37,686 37,686
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
S - Sale X -10,916 1,200 -90.10 60.26 -657,798 72,312
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 3,262 12,116 36.84 12.74 41,558 154,358
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 6,250 8,854 240.02 18.85 117,812 166,898
2018-11-21 2018-11-19 4 RGNX REGENXBIO Inc.
Common Stock
M - Exercise X 2,604 2,604 49.45 128,768 128,768
2018-05-30 2018-05-25 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2017-05-26 2017-05-24 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2016-06-02 2016-06-01 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2015-09-22 2015-09-16 4/A RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 9,375 9,375
2015-09-17 2015-09-16 4 RGNX REGENXBIO Inc.
Stock Option (Right to Buy)
A - Award 5,208 5,208
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -10,531 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -7,665 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -10,905 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options (right to buy)
D - Sale to Issuer -3,594 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options (right to buy)
D - Sale to Issuer -14,844 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options (right to buy)
D - Sale to Issuer -53,089 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options (right to buy)
D - Sale to Issuer -30,615 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
U - Other -75,201 0 -100.00 46.00 -3,459,246
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -859 30,615 -2.73 38.27 -32,874 1,171,636
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2,969 14,844 -16.67 8.21 -24,375 121,869
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3,594 3,594 -50.00 8.25 -29,650 29,650
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 859 75,201 1.16 38.27 32,874 2,877,942
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,969 74,342 4.16 8.21 24,375 610,348
2015-02-20 2015-02-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,594 71,373 5.30 8.25 29,650 588,827
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,531 10,531 -50.00
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -4,789 67,779 -6.60 45.88 -219,719 3,109,701
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 10,531 72,568 16.98
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -3,832 7,665 -33.33
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 10,905 10,905
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -1,427 62,037 -2.25 45.85 -65,428 2,844,396
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,832 63,464 6.43
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -3,148 59,632 -5.01 45.85 -144,336 2,734,127
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 8,967 62,780 16.66
2015-02-09 2015-02-06 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
G - Gift -10,000 62,780 -13.74
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -31,852 53,089 -37.50
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -8,906 17,813 -33.33
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -11,500 9,189 -55.59
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -52,258 72,780 -41.79 35.00 -1,829,030 2,547,300
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 31,852 125,038 34.18 8.23 262,142 1,029,063
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 8,906 93,186 10.57 8.21 73,118 765,057
2014-12-19 2014-12-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 11,500 84,280 15.80 3.34 38,410 281,495
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -10,782 7,188 -60.00
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -31,812 20,689 -60.59
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -4,848 0 -100.00
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -47,442 72,780 -39.46 30.01 -1,423,640 2,183,982
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 10,782 120,222 9.85 8.25 88,952 991,832
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 31,812 109,440 40.98 3.34 106,252 365,530
2014-11-19 2014-11-17 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 4,848 77,628 6.66 5.85 28,361 454,124
2014-11-04 2014-10-31 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 72,780 -12.08 29.00 -290,000 2,110,620
2014-10-29 2014-10-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -30,635 82,780 -27.01 26.75 -819,606 2,214,688
2014-08-15 2014-08-13 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -51,351 23,437 -68.66
2014-08-15 2014-08-13 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -2,462 4,848 -33.68
2014-08-15 2014-08-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 51,351 113,415 82.74 3.34 171,512 378,806
2014-08-15 2014-08-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,462 62,064 4.13 5.85 14,403 363,074
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,530 21,062 -33.33
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -5,459 59,602 -8.39 38.30 -209,080 2,282,757
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 10,530 65,061 19.31
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 11,497 11,497
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 31,474 31,474
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -4,649 54,531 -7.86 35.13 -163,319 1,915,674
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 8,967 59,180 17.86
2014-01-09 2014-01-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -31,588 74,788 -29.69
2014-01-09 2014-01-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -31,588 59,180 -34.80 35.01 -1,105,896 2,071,892
2014-01-09 2014-01-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 31,588 90,768 53.38 3.34 105,504 303,165
2014-01-09 2014-01-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 8,625 106,376 8.82
2013-12-30 2013-12-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -8,624 106,376 -7.50
2013-12-30 2013-12-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -29,250 0 -100.00
2013-12-30 2013-12-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -37,874 59,180 -39.02 30.02 -1,136,977 1,776,584
2013-12-30 2013-12-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 8,624 97,054 9.75 3.34 28,804 324,160
2013-12-30 2013-12-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 29,250 88,430 49.43 5.71 167,018 504,935
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -20,781 26,719 -43.75
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -39,530 17,970 -68.75
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -60,311 59,180 -50.47 24.02 -1,448,387 1,421,225
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 20,781 119,491 21.05 8.21 170,612 981,021
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 39,530 98,710 66.80 8.25 326,122 814,358
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -5,000 7,310 -40.62
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -45,000 0 -100.00
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stcok
S - Sale X -5,000 59,180 -7.79 30.05 -150,255 1,778,418
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -12,000 64,180 -15.75 30.32 -363,840 1,945,938
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -19,000 76,180 -19.96 30.15 -572,774 2,296,522
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -14,000 95,180 -12.82 30.43 -426,006 2,896,232
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 109,180 4.80 5.85 29,250 638,703
2013-09-24 2013-09-20 4 NPSP NPS PHARMACEUTICALS INC
Common Stcok
M - Exercise X 45,000 104,180 76.04 5.71 256,950 594,868
2013-09-17 2013-09-16 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -50,000 0 -100.00
2013-09-17 2013-09-16 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -100 59,180 -0.17 28.65 -2,865 1,695,507
2013-09-17 2013-09-16 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -49,900 59,280 -45.70 27.89 -1,391,711 1,653,319
2013-09-17 2013-09-16 4 NPSP NPS PHARMACEUTICALS INC
Common Stcok
M - Exercise X 50,000 109,180 84.49 4.05 202,500 442,179
2013-05-13 2013-05-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -45,150 50,000 -47.45
2013-05-13 2013-05-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -45,150 59,180 -43.28 14.18 -640,001 838,876
2013-05-13 2013-05-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stcok
M - Exercise X 45,150 104,330 76.29 4.05 182,858 422,536
2013-05-01 2013-04-29 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -4,850 95,150 -4.85
2013-05-01 2013-04-29 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -4,850 59,180 -7.57 14.00 -67,900 828,520
2013-05-01 2013-04-29 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,850 64,030 8.20 4.05 19,642 259,322
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -50,000 100,000 -33.33
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -50,000 59,180 -45.80 12.00 -600,220 710,420
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 50,000 109,180 84.49 4.05 202,500 442,179
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -20,000 0 -100.00
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -6,870 59,180 -10.40 8.01 -55,029 474,032
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common stock
M - Exercise 20,000 66,050 43.43
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 31,592 31,592
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 84,941 84,941
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -3,489 46,050 -7.04 8.61 -30,040 396,490
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
J - Other 8,966 49,539 22.10
2012-12-21 2012-12-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 46,000 46,000
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
A - Award 47,500 47,500
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 26,900 26,900
2012-02-01 2012-01-20 4 NPSP NPS PHARMACEUTICALS INC
Options (right to buy)
A - Award 14,625 14,625
2012-02-01 2012-01-30 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 23,000 23,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)